2.67BMarket Cap-58205P/E (TTM)
43.050High42.160Low223.59KVolume42.370Open42.250Pre Close9.50MTurnover0.95%Turnover RatioLossP/E (Static)62.87MShares64.98052wk High5.39P/B997.11MFloat Cap20.35052wk Low--Dividend TTM23.47MShs Float64.980Historical High--Div YieldTTM2.11%Amplitude4.250Historical Low42.504Avg Price1Lot Size
MoonLake Immunotherapeutics Stock Forum
Ph2 readouts in Q1 2024...
$Leap Therapeutics(LPTX.US)$ Phase 2
$Vera Therapeutics(VERA.US)$ Phase 2b
$4D Molecular Therapeutics(FDMT.US)$ Phase 2
$Adverum Biotechnologies(ADVM.US)$ Phase 2
$Denali Therapeutics(DNLI.US)$ Phase 2
$Akero Therapeutics(AKRO.US)$ Phase 2b
$Spruce Biosciences(SPRB.US)$ Phase 2
$Xencor(XNCR.US)$ Phase 2
$Alnylam Pharmaceuticals(ALNY.US)$ Phase 2
$Harmony Biosciences(HRMY.US)$ Phase 2
$Annexon(ANNX.US)$ Phase 2a
$Roivant Sciences(ROIV.US)$...
Upcoming Ph 2 readouts in Q1 2024…
$Regenxbio(RGNX.US)$ Phase 2
$Leap Therapeutics(LPTX.US)$ Phase 2
$4D Molecular Therapeutics(FDMT.US)$ Phase 2
$Adverum Biotechnologies(ADVM.US)$ Phase 2
$Denali Therapeutics(DNLI.US)$ Phase 2
$EyePoint Pharmaceuticals(EYPT.US)$ Phase 2
$Xencor(XNCR.US)$ Phase 2
$Harmony Biosciences(HRMY.US)$ Phase 2
$Alnylam Pharmaceuticals(ALNY.US)$ Phase 2
$Disc Medicine(IRON.US)$ Phase 2
$Atea Pharmaceuticals(AVIR.US)$ Phase 2
$Allakos(ALLK.US)$ Phase 2...
Caming up
Long and short
The short stock would be $MoonLake Immunotherapeutics(MLTX.US)$ It has just seen its highest run. Once it gets above 50.00 its loses investors interest.
TOP WATCH 6/27 ⚡️⚡️
Price target 120
No comment yet